Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-05-01T23:24:32.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2025-04-24T15:26:29.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed descriptions of a clinical study involving surufatinib and tislelizumab, while adding new information about various cancer types and collaborators.
    Difference
    32%
    Check dated 2025-04-17T10:49:16.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.4) and indicates that results have been submitted, replacing the previous status of no results posted.
    Difference
    1%
    Check dated 2025-04-10T05:29:32.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page has been updated to include information on Neuroendocrine Tumors while removing references to Small Cell Lung Cancer.
    Difference
    0.8%
    Check dated 2025-04-03T00:10:33.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page has been updated to include information on Neuroendocrine Tumors while removing references to Soft Tissue Sarcoma.
    Difference
    0.2%
    Check dated 2025-03-26T12:57:24.000Z thumbnail image

Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.